Your browser doesn't support javascript.
loading
Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.
Seibertz, Fitzwilliam; Rubio, Tony; Springer, Robin; Popp, Fiona; Ritter, Melanie; Liutkute, Aiste; Bartelt, Lena; Stelzer, Lea; Haghighi, Fereshteh; Pietras, Jan; Windel, Hendrik; Pedrosa, Núria Díaz I; Rapedius, Markus; Doering, Yannic; Solano, Richard; Hindmarsh, Robin; Shi, Runzhu; Tiburcy, Malte; Bruegmann, Tobias; Kutschka, Ingo; Streckfuss-Bömeke, Katrin; Kensah, George; Cyganek, Lukas; Zimmermann, Wolfram H; Voigt, Niels.
Affiliation
  • Seibertz F; Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
  • Rubio T; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Springer R; Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), University of Göttingen, Göttingen, Germany.
  • Popp F; Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
  • Ritter M; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Liutkute A; Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
  • Bartelt L; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Stelzer L; Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
  • Haghighi F; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Pietras J; Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
  • Windel H; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Pedrosa NDI; Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
  • Rapedius M; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Doering Y; Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
  • Solano R; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Hindmarsh R; Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
  • Shi R; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Tiburcy M; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Bruegmann T; Department of Cardiothoracic and Vascular Surgery, Georg-August-University Göttingen, Göttingen, Germany.
  • Kutschka I; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Streckfuss-Bömeke K; Department of Cardiothoracic and Vascular Surgery, Georg-August-University Göttingen, Göttingen, Germany.
  • Kensah G; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
  • Cyganek L; Department of Cardiothoracic and Vascular Surgery, Georg-August-University Göttingen, Göttingen, Germany.
  • Zimmermann WH; Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
  • Voigt N; DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
Cardiovasc Res ; 119(16): 2623-2637, 2023 12 19.
Article in En | MEDLINE | ID: mdl-37677054
AIMS: Atrial fibrillation (AF) is associated with tachycardia-induced cellular electrophysiology alterations which promote AF chronification and treatment resistance. Development of novel antiarrhythmic therapies is hampered by the absence of scalable experimental human models that reflect AF-associated electrical remodelling. Therefore, we aimed to assess if AF-associated remodelling of cellular electrophysiology can be simulated in human atrial-like cardiomyocytes derived from induced pluripotent stem cells in the presence of retinoic acid (iPSC-aCM), and atrial-engineered human myocardium (aEHM) under short term (24 h) and chronic (7 days) tachypacing (TP). METHODS AND RESULTS: First, 24-h electrical pacing at 3 Hz was used to investigate whether AF-associated remodelling in iPSC-aCM and aEHM would ensue. Compared to controls (24 h, 1 Hz pacing) TP-stimulated iPSC-aCM presented classical hallmarks of AF-associated remodelling: (i) decreased L-type Ca2+ current (ICa,L) and (ii) impaired activation of acetylcholine-activated inward-rectifier K+ current (IK,ACh). This resulted in action potential shortening and an absent response to the M-receptor agonist carbachol in both iPSC-aCM and aEHM subjected to TP. Accordingly, mRNA expression of the channel-subunit Kir3.4 was reduced. Selective IK,ACh blockade with tertiapin reduced basal inward-rectifier K+ current only in iPSC-aCM subjected to TP, thereby unmasking an agonist-independent constitutively active IK,ACh. To allow for long-term TP, we developed iPSC-aCM and aEHM expressing the light-gated ion-channel f-Chrimson. The same hallmarks of AF-associated remodelling were observed after optical-TP. In addition, continuous TP (7 days) led to (i) increased amplitude of inward-rectifier K+ current (IK1), (ii) hyperpolarization of the resting membrane potential, (iii) increased action potential-amplitude and upstroke velocity as well as (iv) reversibly impaired contractile function in aEHM. CONCLUSIONS: Classical hallmarks of AF-associated remodelling were mimicked through TP of iPSC-aCM and aEHM. The use of the ultrafast f-Chrimson depolarizing ion channel allowed us to model the time-dependence of AF-associated remodelling in vitro for the first time. The observation of electrical remodelling with associated reversible contractile dysfunction offers a novel platform for human-centric discovery of antiarrhythmic therapies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Induced Pluripotent Stem Cells / Atrial Remodeling Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Cardiovasc Res Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Induced Pluripotent Stem Cells / Atrial Remodeling Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Cardiovasc Res Year: 2023 Document type: Article Affiliation country: Country of publication: